{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:21:39Z","timestamp":1794342099794,"version":"4.9.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The General Fund of scientific and technological project of Henan province provincial Health Department","award":["201602008"],"award-info":[{"award-number":["201602008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12894-019-0457-5","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T09:07:39Z","timestamp":1555578459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8595-3588","authenticated-orcid":false,"given":"Qingwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingxiang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"issue":"5","key":"457_CR1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","volume":"68","author":"M Roupret","year":"2015","unstructured":"Roupret M, Babjuk M, Comperat E, et al. European association of urology guidelines on upper urinary tract urothelial cell carcinoma:2015 update. Eur Urol. 2015;68(5):868\u201379.","journal-title":"Eur Urol"},{"issue":"1","key":"457_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"457_CR3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bju.12238","volume":"112","author":"XP Chen","year":"2013","unstructured":"Chen XP, Xiong GY, Li XS, Matin SF, et al. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume Centre in China. BJU Int. 2013;112(7):917\u201324.","journal-title":"BJU Int"},{"issue":"6","key":"457_CR4","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.0.CO;2-B","volume":"85","author":"YH Chou","year":"1999","unstructured":"Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer. 1999;85(6):1342\u20134.","journal-title":"Cancer"},{"issue":"5","key":"457_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0090-4295(02)01529-7","volume":"59","author":"MH Yang","year":"2002","unstructured":"Yang MH, Chen KK, Yen CC, et al. Unusually high incidence of upper tract urothelial carcinoma in Taiwan. Urology. 2002;59(5):681\u20137.","journal-title":"Urology"},{"issue":"5","key":"457_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.eururo.2008.01.054","volume":"54","author":"CC Li","year":"2008","unstructured":"Li CC, Chang TH, Wu WJ, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol. 2008;54(5):1127\u201335.","journal-title":"Eur Urol"},{"issue":"2","key":"457_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.urology.2009.09.048","volume":"75","author":"G Lughezzani","year":"2010","unstructured":"Lughezzani G, Sun M, Perrotte P, et al. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the surveillance, epidemiology, and end results database. Urology. 2010;75(2):321\u20137.","journal-title":"Urology"},{"issue":"1","key":"457_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupr\u00eat","year":"2018","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73(1):111\u201322.","journal-title":"Eur Urol"},{"issue":"1","key":"457_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0022-5347(05)64041-4","volume":"169","author":"I Iborra","year":"2003","unstructured":"Iborra I, Solsona E, Casanova J, Ricos JV, Rubio J, Climent MA. Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression. J Urol. 2003;169(1):82\u20135.","journal-title":"J Urol"},{"issue":"5","key":"457_CR10","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0022-5347(01)64793-1","volume":"157","author":"FJ Keeley","year":"1997","unstructured":"Keeley FJ, Bibbo M, Bagley DH. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol. 1997;157(5):1560\u20135.","journal-title":"J Urol"},{"issue":"4","key":"457_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.urolonc.2009.04.007","volume":"29","author":"JH Ku","year":"2011","unstructured":"Ku JH, Choi WS, Kwak C, Kim HH. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract. Urol Oncol. 2011;29(4):383\u20137.","journal-title":"Urol Oncol"},{"key":"457_CR12","unstructured":"Wu YP, Lin YZ, Lin MY, et al. Risk factors for bladder Cancer recurrence survival in patients with upper-tract urothelial carcinoma. Tumori. 2017:tj5000705."},{"issue":"6","key":"457_CR13","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer. 2009;115(6):1224\u201333.","journal-title":"Cancer"},{"issue":"4","key":"457_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00345-010-0594-7","volume":"29","author":"SF Shariat","year":"2011","unstructured":"Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011;29(4):481\u20136.","journal-title":"World J Urol"},{"issue":"4","key":"457_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","volume":"52","author":"MC Hall","year":"1998","unstructured":"Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52(4):594\u2013601.","journal-title":"Urology"},{"issue":"6","key":"457_CR16","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1464-410X.2006.06524.x","volume":"98","author":"GA Brown","year":"2006","unstructured":"Brown GA, Busby JE, Wood CG, et al. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm? BJU Int. 2006;98(6):1176\u201380.","journal-title":"BJU Int"},{"issue":"2","key":"457_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.urology.2004.09.021","volume":"65","author":"Y Matsui","year":"2005","unstructured":"Matsui Y, Utsunomiya N, Ichioka K, et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology. 2005;65(2):279\u201383.","journal-title":"Urology"},{"issue":"3","key":"457_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s12032-013-0640-6","volume":"30","author":"JY Liu","year":"2013","unstructured":"Liu JY, Li YH, Zhang ZL, et al. Age-specific effect of gender on upper tract urothelial carcinoma outcomes. Med Oncol. 2013;30(3):640.","journal-title":"Med Oncol"},{"issue":"7","key":"457_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int. 2011;107(7):1059\u201364.","journal-title":"BJU Int"},{"issue":"8","key":"457_CR20","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/j.1464-410X.2008.08134.x","volume":"103","author":"G Simone","year":"2009","unstructured":"Simone G, Papalia R, Loreto A. Et al. independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma. BJU Int. 2009;103(8):1052\u20137.","journal-title":"BJU Int"},{"issue":"6","key":"457_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","volume":"57","author":"G Novara","year":"2010","unstructured":"Novara G, Matsumoto K, Kassouf W. Et al. prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract:an international validation study. Eur Urol. 2010;57(6):1064\u201371.","journal-title":"Eur Urol"},{"issue":"6","key":"457_CR22","first-page":"1119","volume":"78","author":"P Hartge","year":"1987","unstructured":"Hartge P, Silverman D, Hoover R, et al. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst. 1987;78(6):1119\u201325.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"457_CR23","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1053\/j.ajkd.2003.11.024","volume":"43","author":"GM Lord","year":"2004","unstructured":"Lord GM, Hollstein M, Arlt VM, et al. DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am J Kidney Dis. 2004;43(4):e11\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"457_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00345-014-1363-9","volume":"33","author":"P Nuhn","year":"2015","unstructured":"Nuhn P, Novara G, Seitz C, et al. Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: resulrs from a retrospective multicenter study. World J Urol. 2015;33(7):1005\u201313.","journal-title":"World J Urol"},{"issue":"4","key":"457_CR25","first-page":"531","volume":"43","author":"L Rongyao","year":"2011","unstructured":"Rongyao L, Peng Z, Xuesong L, et al. Transperitoneal laparoscopic complete nephrectomy for upper urinary tract urothelial carcinoma. Beijing Da Xue Xue Bao. 2011;43(4):531\u20134.","journal-title":"Beijing Da Xue Xue Bao"},{"issue":"5","key":"457_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0090-4295(99)00563-4","volume":"55","author":"T Hisataki","year":"2000","unstructured":"Hisataki T, Miyao N, Masumori N, et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology. 2000;55(5):663\u20137.","journal-title":"Urology."},{"issue":"6","key":"457_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1464-410X.2006.06519.x","volume":"98","author":"RE Zigeuner","year":"2006","unstructured":"Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int. 2006;98(6):1181\u20136.","journal-title":"BJU Int"},{"issue":"11","key":"457_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jfma.2013.11.004","volume":"113","author":"D Fang","year":"2014","unstructured":"Fang D, Xiong GY, Li XS, et al. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience. J Formos Med Assoc. 2014;113(11):820\u20137.","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"457_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/bju.13935","volume":"120","author":"M Marchioni","year":"2017","unstructured":"Marchioni M, Giulia P, Luca C, et al. Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis. BJU Int. 2017;120(3):313\u20139.","journal-title":"BJU Int"},{"issue":"7","key":"457_CR30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/j.1464-410X.2005.05804.x","volume":"96","author":"JD Raman","year":"2005","unstructured":"Raman JD, Ng CK, Boorjian SA, Vaughan EJ, Sosa RE, Scherr DS. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int. 2005;96(7):1031\u20135.","journal-title":"BJU Int"},{"issue":"11","key":"457_CR31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1442-2042.2011.02845.x","volume":"18","author":"EC Hwang","year":"2011","unstructured":"Hwang EC, Kim YJ, Hwang IS, et al. Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma:a retrospective cohort study. Int J Urol. 2011;18(11):769\u201376.","journal-title":"Int J Urol"},{"issue":"2","key":"457_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.diabres.2010.11.009","volume":"91","author":"S Liu","year":"2011","unstructured":"Liu S, Li Y, Lin T, Fan X, Liang Y, Heemann U. High dose human insulin and insulin glargine promote T24 bladder cancer cell proliferation via P13K\u2014independent activation of Akt. Diabetes Res Clin Praet. 2011;91(2):177\u201382.","journal-title":"Diabetes Res Clin Praet"},{"issue":"5","key":"457_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1593\/neo.11148","volume":"13","author":"R Rattan","year":"2011","unstructured":"Rattan R, Graham RP, Maguire JL, Giri S, Shridhar V. Mefformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia. 2011;13(5):483\u201391.","journal-title":"Neoplasia"},{"issue":"2","key":"457_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ygyno.2008.04.008","volume":"110","author":"WH Gotlieb","year":"2008","unstructured":"Gotlieb WH, Saumet J, Beauchamp MC, et al. In vitro metforminanti\u2014neoplastic activity in epithelial ovarian cancer. Gynecol Oncol. 2008;110(2):246\u201350.","journal-title":"Gynecol Oncol"},{"issue":"13","key":"457_CR35","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","volume":"46","author":"M Jalving","year":"2010","unstructured":"Jalving M, Gietema JA, Lefrandt JD, et al. Metformin:taking away the candyfor cancer. EurJ Cancer. 2010;46(13):2369\u201380.","journal-title":"EurJ Cancer"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-019-0457-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12894-019-0457-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-019-0457-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T01:46:26Z","timestamp":1721180786000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-019-0457-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1186\/s12894-019-0457-5","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,18]]},"assertion":[{"value":"9 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research adopted the retrospective analysis based on the principle of safety and fairness. The diagnosis and treatment conducted had no harm on the health of the subjects, and there was no risk for the subjects. All subjects signed the informed consent and their personal information would not be disclosed. Moreover, the research was beneficial and instructive for clinical practice. Based on the discussion of the medical scientific ethical committee of the First affiliated hospital of Zhengzhou University, this study was approved.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"24"}}